Revenue (Quarterly) Chart

Historical Revenue (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 3.947B
March 31, 2026 3.831B
December 31, 2025 4.324B
September 30, 2025 4.250B
June 30, 2025 4.101B
March 31, 2025 3.683B
December 31, 2024 4.209B
September 30, 2024 4.122B
June 30, 2024 3.738B
March 31, 2024 3.854B
December 31, 2023 4.190B
September 30, 2023 4.295B
June 30, 2023 4.175B
March 31, 2023 4.206B
December 31, 2022 4.380B
September 30, 2022 4.227B
June 30, 2022 4.273B
March 31, 2022 4.717B
December 31, 2021 5.172B
September 30, 2021 5.083B
June 30, 2021 4.945B
March 31, 2021 4.913B
December 31, 2020 5.405B
September 30, 2020 4.951B
June 30, 2020 4.806B
Date Value
March 31, 2020 4.835B
December 31, 2019 5.265B
September 30, 2019 5.289B
June 30, 2019 4.972B
March 31, 2019 4.792B
December 31, 2018 5.078B
September 30, 2018 4.595B
June 30, 2018 4.763B
March 31, 2018 4.679B
December 31, 2017 5.052B
September 30, 2017 4.678B
June 30, 2017 4.748B
March 31, 2017 4.519B
December 31, 2016 5.107B
September 30, 2016 5.102B
June 30, 2016 4.933B
March 31, 2016 4.974B
December 31, 2015 5.103B
September 30, 2015 4.308B
June 30, 2015 4.197B
March 31, 2015 4.142B
December 31, 2014 4.691B
September 30, 2014 4.599B
June 30, 2014 4.517B
March 31, 2014 4.878B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Medipal Holdings Corp. 6.209B
Vital KSK Holdings, Inc. 970.17M
Cencora, Inc. 84.75B
Cardinal Health, Inc. 63.67B
McKesson Corp. 105.38B